Tyenne
Tyenne is a subject whose supplied evidence does not describe any commercial brand, company, or product platform.
Last updated October 31, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
The supplied evidence for this entry does not contain any information about a commercial entity named Tyenne. The only material provided consists of two news items about a lawsuit concerning President Donald Trump's media company and early access to Truth Social posts; neither item mentions Tyenne, a product, a company, or a brand of any kind. Because no brand-sense evidence exists in the source material, this dossier cannot responsibly describe Tyenne's origin, offerings, ownership, headquarters, or market positioning. The entry is therefore flagged for review rather than filled with speculative content. If Tyenne is in fact a commercial brand — for example a pharmaceutical or consumer product trademark — additional authoritative sources such as an official website, regulatory filing, or encyclopedia entry would be required before a full dossier could be written.
Controversies
2026
Tyenne arthritis injection vials recalled nationwide over glass particles
The FDA warned that 400 mg/20 mL Tyenne (tocilizumab-aazg) injection vials, lot 16UI07, are being recalled nationwide after an internal investigation at the manufacturer found glass particles in the affected vials. The FDA said administering a recalled vial can cause local irritation, pain or swelling at the infusion site, vein inflammation, and in serious cases blocked blood flow, pulmonary embolism, permanent organ damage or death. No injuries or illnesses had been reported at the time.
Recent events
- Unconfirmed
Reported
Tyenne arthritis injection vials recalled nationwide over glass particles[3]
The FDA warned that 400 mg/20 mL Tyenne (tocilizumab-aazg) injection vials, lot 16UI07, are being recalled nationwide after an internal investigation at the manufacturer found glass particles in the affected vials. The FDA said administering a recalled vial can cause local irritation, pain or swelling at the infusion site, vein inflammation, and in serious cases blocked blood flow, pulmonary embolism, permanent organ damage or death. No injuries or illnesses had been reported at the time.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/tyenne · Editorial policy · How profiles are compiled